USPTO serial 79259148
DIAGNOSTICS DEFINING THERAPY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 28, 2020
- Examiner
- BUSH, KAREN K
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with DIAGNOSTICS DEFINING THERAPY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,295*
Plus Government fees of $2,125
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joi A. White
Joi A. White Carr & Ferrell LLP411 Borel Avenue, Suite 603San Mateo, CA 94402UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry, science, photography, agriculture, horticulture and forestry, except fungicides, herbicides, insecticides, and parasiticides; reagents and reactants for non-medical purposes; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acids for other than medical and veterinary purposes; acids, namely inorganic acids for industrial purposes; DNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations and substances; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; enzymes for pharmaceutical, veterinary and medical purposes; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; clinical diagnostics for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders | ACTIVE | — |
| 010 | Surgical, medical and veterinary apparatus and instruments; diagnostic testing apparatus and instruments for medical purposes; diagnostic testing kits containing diagnostic testing apparatus; point of care medical devices; screening kits in this class comprised of medical screening and testing apparatus for the diagnosis of disease, detection and/or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, and scientific research consulting in the field of genetics; genetic research; genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services, namely, chemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of diagnostic apparatus for genetics research; design of diagnostic apparatus for genetics research; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, dna, rna, protein, polynucleic acid and molecular analysis and evaluation services; dna and rna and polynucleic acid and protein sequencing, analysis and evaluation services; genome sequencing services and the analysis and evaluation of data resulting therefrom; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services; custom design and development of biochemical assays; molecular diagnostics testing | ACTIVE | — |
| 044 | Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to dna, genetics and genetic testing; medical diagnostic services in the nature of medical testing and medical analysis; providing collected and analysed medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; diagnostic imaging for medical purposes and molecular medicine healthcare services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SpeeDx Pty Ltd
- Other trademarks owned by SpeeDx Pty Ltd
- Other trademarks owned by SpeeDx Pty Ltd
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named DIAGNOSTICS DEFINING THERAPY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 28, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 8, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 8, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 8, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 13, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 26, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 6, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 31, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 28, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 28, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 14, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 11, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 11, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 29, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 29, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 22, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 7, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 19, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 18, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 17, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 17, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 12, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 24, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 24, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 5, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 4, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 1, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 28, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 28, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 23, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |